Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control

Phil Jun Kang, Jie Zheng, Gilju Lee, Daryeon Son, In Yong Kim, Gwonhwa Song, Gyuman Park, Seungkwon You

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Reprogramming of ‘adult’ differentiated somatic cells to ‘embryonic’ pluripotent stem cells accompanied by increased rate of glycolysis. Conversely, glycolysis triggers accumulation of advanced glycation end products (AGEs), a potential causative factor in aging, by promoting methylglyoxal production. Therefore, it is reasonable that pluripotent stem cells (PSCs) would specifically regulate glycolysis to maintain their embryonic features. In this study, we focused on glycine decarboxylase (GLDC), a key enzyme in the glycine cleavage system that regulates glycolysis and methylglyoxal production in cancer. GLDC was exclusively expressed in PSCs, and inhibition of this enzyme induced alterations of metabolome and AGE accumulation, thereby suppressing the embryonic pluripotent state. Surprisingly, the level of accumulated AGEs in somatic cells gradually decreased during reprogramming, ultimately disappearing in iPSCs. In addition, ectopic expression of GLDC or treatment with the AGE inhibitor LR-90 promoted reprogramming. Together, these findings suggest that GLDC-mediated regulation of glycolysis and controlling AGE accumulation is related to maintenance and induction of pluripotency.

Original languageEnglish
Pages (from-to)35-47
Number of pages13
JournalMetabolic Engineering
Volume53
DOIs
Publication statusPublished - 2019 May 1

Fingerprint

Glycine Dehydrogenase (Decarboxylating)
Glycolysis
Amino acids
Pluripotent Stem Cells
Maintenance
Stem cells
Pyruvaldehyde
Enzymes
Enzyme inhibition
Advanced Glycosylation End Products
Metabolome
Embryonic Stem Cells
Aging of materials

Keywords

  • Advanced glycation end product (AGE)
  • Glycine decarboxylase (GLDC)
  • Glycolysis
  • Methylglyoxal
  • Pluripotent stem cell
  • Reprogramming

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control. / Kang, Phil Jun; Zheng, Jie; Lee, Gilju; Son, Daryeon; Kim, In Yong; Song, Gwonhwa; Park, Gyuman; You, Seungkwon.

In: Metabolic Engineering, Vol. 53, 01.05.2019, p. 35-47.

Research output: Contribution to journalArticle

Kang, Phil Jun ; Zheng, Jie ; Lee, Gilju ; Son, Daryeon ; Kim, In Yong ; Song, Gwonhwa ; Park, Gyuman ; You, Seungkwon. / Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control. In: Metabolic Engineering. 2019 ; Vol. 53. pp. 35-47.
@article{c404af2cbd6d4ae999030a597014c6cc,
title = "Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control",
abstract = "Reprogramming of ‘adult’ differentiated somatic cells to ‘embryonic’ pluripotent stem cells accompanied by increased rate of glycolysis. Conversely, glycolysis triggers accumulation of advanced glycation end products (AGEs), a potential causative factor in aging, by promoting methylglyoxal production. Therefore, it is reasonable that pluripotent stem cells (PSCs) would specifically regulate glycolysis to maintain their embryonic features. In this study, we focused on glycine decarboxylase (GLDC), a key enzyme in the glycine cleavage system that regulates glycolysis and methylglyoxal production in cancer. GLDC was exclusively expressed in PSCs, and inhibition of this enzyme induced alterations of metabolome and AGE accumulation, thereby suppressing the embryonic pluripotent state. Surprisingly, the level of accumulated AGEs in somatic cells gradually decreased during reprogramming, ultimately disappearing in iPSCs. In addition, ectopic expression of GLDC or treatment with the AGE inhibitor LR-90 promoted reprogramming. Together, these findings suggest that GLDC-mediated regulation of glycolysis and controlling AGE accumulation is related to maintenance and induction of pluripotency.",
keywords = "Advanced glycation end product (AGE), Glycine decarboxylase (GLDC), Glycolysis, Methylglyoxal, Pluripotent stem cell, Reprogramming",
author = "Kang, {Phil Jun} and Jie Zheng and Gilju Lee and Daryeon Son and Kim, {In Yong} and Gwonhwa Song and Gyuman Park and Seungkwon You",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.ymben.2019.02.003",
language = "English",
volume = "53",
pages = "35--47",
journal = "Metabolic Engineering",
issn = "1096-7176",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control

AU - Kang, Phil Jun

AU - Zheng, Jie

AU - Lee, Gilju

AU - Son, Daryeon

AU - Kim, In Yong

AU - Song, Gwonhwa

AU - Park, Gyuman

AU - You, Seungkwon

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Reprogramming of ‘adult’ differentiated somatic cells to ‘embryonic’ pluripotent stem cells accompanied by increased rate of glycolysis. Conversely, glycolysis triggers accumulation of advanced glycation end products (AGEs), a potential causative factor in aging, by promoting methylglyoxal production. Therefore, it is reasonable that pluripotent stem cells (PSCs) would specifically regulate glycolysis to maintain their embryonic features. In this study, we focused on glycine decarboxylase (GLDC), a key enzyme in the glycine cleavage system that regulates glycolysis and methylglyoxal production in cancer. GLDC was exclusively expressed in PSCs, and inhibition of this enzyme induced alterations of metabolome and AGE accumulation, thereby suppressing the embryonic pluripotent state. Surprisingly, the level of accumulated AGEs in somatic cells gradually decreased during reprogramming, ultimately disappearing in iPSCs. In addition, ectopic expression of GLDC or treatment with the AGE inhibitor LR-90 promoted reprogramming. Together, these findings suggest that GLDC-mediated regulation of glycolysis and controlling AGE accumulation is related to maintenance and induction of pluripotency.

AB - Reprogramming of ‘adult’ differentiated somatic cells to ‘embryonic’ pluripotent stem cells accompanied by increased rate of glycolysis. Conversely, glycolysis triggers accumulation of advanced glycation end products (AGEs), a potential causative factor in aging, by promoting methylglyoxal production. Therefore, it is reasonable that pluripotent stem cells (PSCs) would specifically regulate glycolysis to maintain their embryonic features. In this study, we focused on glycine decarboxylase (GLDC), a key enzyme in the glycine cleavage system that regulates glycolysis and methylglyoxal production in cancer. GLDC was exclusively expressed in PSCs, and inhibition of this enzyme induced alterations of metabolome and AGE accumulation, thereby suppressing the embryonic pluripotent state. Surprisingly, the level of accumulated AGEs in somatic cells gradually decreased during reprogramming, ultimately disappearing in iPSCs. In addition, ectopic expression of GLDC or treatment with the AGE inhibitor LR-90 promoted reprogramming. Together, these findings suggest that GLDC-mediated regulation of glycolysis and controlling AGE accumulation is related to maintenance and induction of pluripotency.

KW - Advanced glycation end product (AGE)

KW - Glycine decarboxylase (GLDC)

KW - Glycolysis

KW - Methylglyoxal

KW - Pluripotent stem cell

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=85061673231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061673231&partnerID=8YFLogxK

U2 - 10.1016/j.ymben.2019.02.003

DO - 10.1016/j.ymben.2019.02.003

M3 - Article

C2 - 30779965

AN - SCOPUS:85061673231

VL - 53

SP - 35

EP - 47

JO - Metabolic Engineering

JF - Metabolic Engineering

SN - 1096-7176

ER -